Derr RL, Ye X, Islas MU, Desideri S, Saudek CD, Grossman SA
Although a HR below unity suggests a possible protective association, the absolute risk reduction was very small, and this finding should be considered tentative and hypothesis-generating
Novo GLP-1 drug shows less lean mass loss than rivals, study says Eli Lilly's LLY.N GLP-1 drug tirzepatide yields greater weight loss on average than Novo Nordisk's NOVOb.CO semaglutide, but at a greater expense to muscles and connective tissues, according to a study published this week ahead of peer review
Glutathione is a naturally synthesized molecule in the body's cells
309 , E1008E1018 (2015)
Semaglutide is losing patent exclusivity in over 80 countries this year, with several drugmakers including Dr Reddys, Sun Pharma, Biocon and Ajanta Pharma targeting both regulated and emerging markets